Ananya et al. found that a vitamin D analog exhibited a significantly immunosuppressive effect on immunocytes from psoriasis patients compared to the conventional psoriasis therapeutic agent vitamin D, which was via downregulating the AKT/mTOR signaling cascade [43]. This evidence concerns the gene AKT1 and psoriasis.